Narrative review / 2013
A review of recent studies found isoflavones and equol-producer status were linked to a decreased risk of prostate cancer.
Researchers reviewed recent epidemiological studies and microbiological research published between 2008 and 2012 regarding isoflavone intake, equol-producing flora, and prostate cancer (PCa) risk. Five out of six articles showed a significant association of isoflavones with a decreased risk of PCa, and two of these consistently reported that equol-producers have a significantly reduced risk. Additionally, five human intestinal bacteria capable of converting daidzein into equol were identified within the evaluated timeframe.
Shows an association, not proof of cause and effect.
- Study type
- Review of epidemiological and microbiological studies (2008-2012)
- Who was studied
- Human populations from studies published between 2008 and 2012
- What was measured
- Prostate cancer risk and identification of equol-converting bacteria
THE PAPER
Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk.
Sugiyama Y, Masumori N, Fukuta F, Yoneta A, Hida T, Yamashita T, Minatoya M, Nagata Y, Mori M, Tsuji H, Akaza H, Tsukamoto T. Asian Pac J Cancer Prev, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.